Abstract 1291
Case Summary
Patient. 46 years old. Female. Has been ill since 6 month. Has not another diseases. Family history free. Endoscopy has shown submucosal lesion with infiltrative tumor on the antrum. The size of the submocosal lesion was 2,5 x 3.0 cm. The overlying mucosa in the middle of the submucosal lesion was ulterated. The biopsies have taken from both sites. Histologic examination of infiltrative region revealed adenocarcinoma G3. Biopsies of submucosal lesion was negative. The physical examination and routine laboratory tests upon admission were unremarkable. The histopathologic examination after operation has revealed an adenocarcinoma G3 of stomach, that has been infiltrating into the muscular layer. In microscopic examination of submucosal lesion have been found a spindle cells neoplasm located in muscularis propria extending up to serosa. In immunohistochemical studing for desmin and CD-117 which confermed the diagnosis of gastrointestinal stromal tumor. The mitotic count was 6/50 HPF. Also, in the side with ulceration of GIST have been found cells of adenocarcinoma. The patient has been undergone distal subtotal gastrectomy and Billroth-II gastrojejunal anastomosis with D2 lymphadenectomy. The patient has not received imatinibas adjuvant therapy for the GIST, according to the international guidelines for GISTs risk stratification. The patient underwent regular clinical and radiological follow-up every 4 months after discharge. No evidence of tumor recurrence was found after 12 months of follow-up.
Editorial acknowledgement
Clinical trial identification
Resources from the same session
750 - HER2 positive rates in Invasive Lobular Breast Carcinoma : A study amongst 1,095 consecutive Asian patients
Presenter: Ga Jing Kee
Session: Poster display - Cocktail
Resources:
Abstract
1417 - CanAssist-breast -an immunohistochemistry based test for risk of recurrence prediction for early stage breast cancer patients: a cost-effective and accurate solution for Asia
Presenter: Manjiri Bakre
Session: Poster display - Cocktail
Resources:
Abstract
1468 - Topical silymarin administration for prevention of radiodermatitis in breast cancer patients: a randomized, double-blind, placebo-controlled clinical trial
Presenter: Sepideh Elyasi
Session: Poster display - Cocktail
Resources:
Abstract
873 - Comparison of interstitial brachytherapy with volumetric modulated arc therapy for tumour bed boost following breast conservative surgery
Presenter: Kannan Periasamy
Session: Poster display - Cocktail
Resources:
Abstract
1140 - Triple Negative Breast Cancer and Platinum-based Systemic Treatment: Meta-analysis and Systematic Review
Presenter: Jessa Gilda Pandy
Session: Poster display - Cocktail
Resources:
Abstract
168 - Longitudinal study on incidences of obesity and weight changes in Chinese patients with early-stage breast cancer
Presenter: Winnie Yeo
Session: Poster display - Cocktail
Resources:
Abstract
311 - Effect of combined CYP2C19 and CYP2D6 genotype on tamoxifen treatment outcome in breast cancer indicates endogenous and exogenous interplay
Presenter: Hanjing Xie
Session: Poster display - Cocktail
Resources:
Abstract
669 - A novel nipple aleolar complex involvement predictive index (NACPI) for indicating nipple sparing mastectomy in breast cancer
Presenter: Hirohito Seki
Session: Poster display - Cocktail
Resources:
Abstract
938 - Multicenter Trial for Safety and Toxicity of Nanoxel®M in Breast Cancer
Presenter: Tae Hyun Kim
Session: Poster display - Cocktail
Resources:
Abstract
1129 - Implication of PET-CT to improve negative predictive value for axillary lymph node metastasis in early breast cancer
Presenter: Oyeon Cho
Session: Poster display - Cocktail
Resources:
Abstract